These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 34277627)
1. Comprehensive Analysis of the Immune-Oncology Targets and Immune Infiltrates of Zhang X; Shen L; Cai R; Yu X; Yang J; Wu X; Zhu Y; Liu X Front Cell Dev Biol; 2021; 9():686675. PubMed ID: 34277627 [TBL] [Abstract][Full Text] [Related]
2. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation. Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity. Xiong Z; Li X; Yin S; Xie M; Mao C; Zhang F; Chen H; Jin L; Lian L Front Mol Biosci; 2021; 8():724889. PubMed ID: 34712696 [No Abstract] [Full Text] [Related]
4. A new risk model based on a 11-m Lei L; Li N; Yuan P; Liu D BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776 [TBL] [Abstract][Full Text] [Related]
5. Using immune-related lncRNAs to construct novel biomarkers and investigate the immune landscape of breast cancer. Qin M; Ma Y; Wang Z; Fang D; Wei J Transl Cancer Res; 2021 Jun; 10(6):2991-3003. PubMed ID: 35116607 [TBL] [Abstract][Full Text] [Related]
6. N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia. Zhang L; Ke W; Hu P; Li Z; Geng W; Guo Y; Song B; Jiang H; Zhang X; Wan C Front Genet; 2022; 13():804614. PubMed ID: 35615374 [No Abstract] [Full Text] [Related]
7. Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer. Huang J; Chen W; Chen C; Jie Z; Xiao T Int J Gen Med; 2022; 15():2629-2643. PubMed ID: 35300127 [TBL] [Abstract][Full Text] [Related]
9. Construction and validation of a nomogram based on N6-Methylandenosine-related lncRNAs for predicting the prognosis of non-small cell lung cancer patients. Xiao W; Geng W; Xu J; Huang Q; Fan J; Tan Q; Yin Z; Li Y; Yang G; Jin Y Cancer Med; 2023 Jan; 12(2):2058-2074. PubMed ID: 35726651 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma. Dai T; Li J; Ye L; Yu H; Deng M; Liu W; Li H; Yang Y; Wang G J Clin Transl Hepatol; 2022 Apr; 10(2):308-320. PubMed ID: 35528973 [TBL] [Abstract][Full Text] [Related]
11. Autophagy related long non-coding RNA and breast cancer prognosis analysis and prognostic risk model establishment. Luo Z; Nong B; Ma Y; Fang D Ann Transl Med; 2022 Jan; 10(2):58. PubMed ID: 35282059 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m Xu Y; He X; Deng J; Xiong L; Li Y; Zhang X; Chen W; Liu X; Xu X Front Cell Dev Biol; 2021; 9():681745. PubMed ID: 34277622 [TBL] [Abstract][Full Text] [Related]
13. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network. Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658 [TBL] [Abstract][Full Text] [Related]
14. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer. Zheng J; Guo J; Cao B; Zhou Y; Tong J Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA. Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543 [TBL] [Abstract][Full Text] [Related]
16. An Immune-Related Long Noncoding RNA Pair as a New Biomarker to Predict the Prognosis of Patients in Breast Cancer. Jiang H; Sun J; Liu F; Wu X; Wen Z Front Genet; 2022; 13():895200. PubMed ID: 35812755 [No Abstract] [Full Text] [Related]
17. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer. Wu Q; Zheng S; Lin N; Xie X BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532 [TBL] [Abstract][Full Text] [Related]
18. Integrated Analysis of the Immune Infiltrates and PD-L1 Expression of N6-Methyladenosine-Related Long Non-Coding RNAs in Colorectal Cancer. Jiang Z; Zhang Y; Chen K; Yang X; Liu J Int J Gen Med; 2021; 14():5017-5028. PubMed ID: 34511985 [TBL] [Abstract][Full Text] [Related]
19. A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer. Li X; Chen J; Yu Q; Huang H; Liu Z; Wang C; He Y; Zhang X; Li W; Li C; Zhao J; Long W Front Genet; 2021; 12():569318. PubMed ID: 33796128 [No Abstract] [Full Text] [Related]
20. N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy. Zhang MM; Lin YL; Zeng WF; Li Y; Yang Y; Liu M; Ye YJ; Jiang KW; Wang S; Wang S Front Genet; 2021; 12():790888. PubMed ID: 34976022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]